Physician profile
Kimberly Flake
NPI 1669733838
$2,684.01
in general payments reported to CMS, 2019-2025
21 companies · $74.27 in 2025
The $74.27 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $333 · 2022: $1,506 · 2023: $549 · 2024: $221 · 2025: $74.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $844.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,333.95 | 2021-2024 | Wavewriter Alpha Prime 16, Varithena Administration Pack |
| Nevro Corp. | $269.58 | 2022-2024 | Senza |
| Abbvie INC. | $217.11 | 2021-2025 | |
| Lilly USA, LLC | $169.40 | 2021-2022 | |
| Tris Pharma INC | $132.55 | 2023 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $86.47 | 2022 | |
| Collegium Pharmaceutical, INC. | $74.95 | 2022-2024 | Belbuca |
| Janssen Pharmaceuticals, INC | $56.55 | 2022-2025 | Invega Sustenna |
| Scilex Pharmaceuticals INC. | $46.77 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $38.13 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.55 | 2021 | |
| Grt US Holding, INC. | $34.46 | 2021 | |
| Amgen INC. | $27.66 | 2022 | |
| Biodelivery Sciences International, INC. | $26.66 | 2021 | |
| Abbott Laboratories | $21.49 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.30 | 2023 | |
| Fidia Pharma USA INC. | $19.60 | 2024 | Hyalgan, Hymovis, Triluron |
| Merz North America, INC. | $19.38 | 2024 | |
| Lundbeck LLC | $19.33 | 2021 | |
| Alkermes, INC. | $18.05 | 2025 | Aristada, Lybalvi |
| Spinal Simplicity, LLC | $13.07 | 2023 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Flake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.